Page last updated: 2024-11-06

hydroxyproline and Ovarian Neoplasms

hydroxyproline has been researched along with Ovarian Neoplasms in 3 studies

Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, PL1
Zhang, X1
Li, TF1
Wang, LL1
Du, LT1
Yang, YM1
Li, J1
Wang, HY1
Zhang, Y1
Wang, CX1
Waalkes, TP1
Rosenshein, NB1
Shaper, JH1
Ettinger, DS1
Woo, KB1
Paone, JF1
Gehrke, CW1
Kauppila, S1
Bode, MK1
Stenbäck, F1
Risteli, L1
Risteli, J1

Other Studies

3 other studies available for hydroxyproline and Ovarian Neoplasms

ArticleYear
Combined detection of sialic acid and hydroxyproline in diagnosis of ovarian cancer and its comparison with human epididymis protein 4 and carbohydrate antigen 125.
    Clinica chimica acta; international journal of clinical chemistry, 2015, Jan-15, Volume: 439

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; CA-125 Antigen; Female; Humans; Hydroxyproline; M

2015
A feasibility study in the development of biological markers for ovarian cancer.
    Journal of surgical oncology, 1982, Volume: 21, Issue:4

    Topics: Aminoisobutyric Acids; Body Fluids; Carcinoembryonic Antigen; Chorionic Gonadotropin; Cystadenocarci

1982
Cross-linked telopeptides of type I and III collagens in malignant ovarian tumours in vivo.
    British journal of cancer, 1999, Volume: 81, Issue:4

    Topics: Collagen; Collagen Type I; Female; Humans; Hydroxyproline; Immunohistochemistry; Ovarian Neoplasms;

1999